CVS Health to issue $5B in senior notes across five tranches

CVS HEALTH Corp

Aggregate principal: $1B 5.000% notes due 2029, $750M 5.250% notes due 2031, $1.25B 5.300% notes due 2033, $1.25B 5.875% notes due 2053, $750M 6.000% notes due 2063.
Net proceeds to CVS estimated at approximately $4.938B after underwriter discounts and expenses.
Offering expected to close June 2, 2023, subject to customary conditions.
Underwriters include Barclays, BofA Securities, Goldman Sachs, J.P. Morgan, and Wells Fargo Securities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.